.no-js-message{position:fixed;top:0;left:0;right:0;background:#222;color:#fff;padding:8px 12px;font-size:14px;z-index:10000;text-align:center}JavaScript is disabled. The site works, but some features may be limited.

INDIA
MONEY
TRAVELLER
EATS
RESPAWN
LUXE

Get magazine delivered to your doorstep

Get latest issue delivered instantly

Only in Delhi-NCR, Mumbai, Bengaluru, Pune, Lucknow & Kolkata

Delivery within India

Delivery outside India

Get magazine delivered to your doorstep

Get latest issue delivered instantly

Only in Delhi-NCR, Mumbai, Bengaluru, Pune, Lucknow & Kolkata

C3
Magazine
Markets
Corporate
- Corporate Strategist
- Down the Ages
Economy & Policy
- Nash Equilibria
- Essays
Newsletters
News
AI
Videos
Start-Up
Planet

Budget 2026
Magazine
Markets
OB Datalens
Corporate
- Corporate Strategist
- Down the Ages
Economy & Policy
- Nash Equilibria
- Essays
Newsletters
News
AI
Videos
Start-Up
Planet
Tech
Spotlight
Magazine Special Edition
Initiatives
- Spotlight
- C3
About Us

C3
Magazine
Markets
Corporate
Economy & Policy
Newsletters
News
AI
Videos
Start-Up
Planet

home
Topic
Dr reddys labs

Dr Reddys Labs

Sun Pharma, Dr Reddys, Glenmark Launch Generic Semaglutide Injection in India

Sun Pharma, Dr Reddy's, Glenmark Launch Generic Semaglutide Injection in India

BY PTI

Dr Reddy’s Lab Shares Rise 4% On Pact With Alvotech For Biosimilar Development

Dr Reddy’s Lab Shares Rise 4% On Pact With Alvotech For Biosimilar Development

BY Outlook Business Desk

Dr Reddy Laboratories

Dr Reddy's PAT Zooms 18% To Rs 1,402 Crore In Q1

BY PTI

Dr Reddys Laboratories recalls 4,320 bottles of Tacrolimus Capsules in the US

Dr Reddy's Lab Recalls Over 4,000 Bottles Of Generic Drug In US

BY PTI

Pharma sector

Dr Reddy's, Sun Pharma Recall Products In US For Manufacturing Issues

BY Press Trust of India

Dr Reddy Laboratories

Intercept Pharmaceuticals Settles Ocaliva Patent Litigation Case With Dr Reddy's

BY Press Trust of India

Dr Reddys Launches Cancer Treatment Injection Bortezomib In US

Dr Reddy's Launches Cancer Treatment Injection Bortezomib In US

BY Press Trust of India

Advertisement

Stock Market Today: Sensex Falls Over 200 Points, Nifty Below 15,300

Stock Market Today: Sensex Falls Over 200 Points, Nifty Below 15,300

BY Outlook Business Desk

Group Publications

About Us
Contact Us
Terms and Conditions
Privacy Policy

Copyright © 2026 Outlook Publishing India Pvt Ltd.

Copyright © 2026 Outlook Publishing India Pvt Ltd. All pages of the Website are subject to our terms and conditions and privacy policy. You must not reproduce, duplicate, copy, sell, resell or exploit any material on the Website for any commercial purposes.